Merck’s stock tumbled 6% early Tuesday, after the drug company’s softer-than-expected guidance for the current year offset better-than-expected fourth-quarter earnings.
Tag:
Beat
-
-
European markets mixed ahead of Fed decision, ASML gains on Q4 beat
Older Posts
